Hospital Novy Jicin

Nový Jičín 74101

0 studies enrolling now · 3 studies all time

What they study most

HER2+ Metastatic Breast Cancer (MBC), Short Bowel Syndrome

Studies at this site

• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. — Running, not enrolling
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed